PDS Biotechnology Corporation (PDSB)

NASDAQ: PDSB · Real-Time Price · USD

1.310

+0.030 (2.34%)

At close: Apr 17, 2026, 4:00 PM EDT

1.319

+0.009 (0.71%)

After-hours: Apr 17, 2026, 7:42 PM EDT

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26.71	41.69	56.56	73.82	65.24
Cash & Short-Term Investments	26.71	41.69	56.56	73.82	65.24
Cash Growth	-35.93%	-26.29%	-23.38%	13.15%	126.23%
Other Current Assets	1.54	3.36	2.49	2.66	1.6
Total Current Assets	28.25	45.05	59.06	76.48	66.84
Net Property, Plant & Equipment	0.24	0.3	0.34	0.53	0.36
Other Long-Term Assets	2	-	-	-	-
Total Assets	30.49	45.36	59.39	77.01	67.2
Accounts Payable	3.57	1.68	6.98	1.22	1.31
Accrued Expenses	0.74	2.84	2.42	8.31	2.19
Short-Term Debt	5.13	12.5	4.17	-	-
Current Portion of Leases	0.04	0.06	0.06	0.29	0.26
Total Current Liabilities	9.48	17.09	13.63	9.82	3.76
Long-Term Debt	11.73	9.2	19.51	23.02	-
Long-Term Leases	0.03	0.06	0.12	0.16	0.23
Total Long-Term Liabilities	11.76	9.27	19.63	23.18	0.23
Total Liabilities	21.24	26.35	33.26	33.01	3.99
Common Stock	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	225.84	201.1	170.62	145.55	123.91
Retained Earnings	-216.61	-182.11	-144.5	-101.56	-60.7
Shareholders' Equity	9.25	19	26.13	44	63.21
Total Liabilities & Equity	30.49	45.36	59.39	77.01	67.2
Total Debt	16.93	21.83	23.85	23.47	0.49
Net Cash (Debt)	9.79	19.86	32.71	50.35	64.75
Net Cash Growth	-50.73%	-39.28%	-35.03%	-22.25%	129.38%
Net Cash Per Share	0.21	0.55	1.06	1.76	2.53
Book Value	9.25	19	26.13	44	63.21
Book Value Per Share	0.20	0.52	0.84	1.54	2.47
Tangible Book Value	9.25	19	26.13	44	63.21
Tangible Book Value Per Share	0.20	0.52	0.84	1.54	2.47

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q